Skip to main content
Erschienen in: Medical Oncology 1/2013

01.03.2013 | Original Paper

Expression analysis of four testis-specific genes AURKC, OIP5, PIWIL2 and TAF7L in acute myeloid leukemia: a gender-dependent expression pattern

verfasst von: Fatemeh Yazarloo, Reza Shirkoohi, Maryam Beigom Mobasheri, Amirhossein Emami, Mohammad Hossein Modarressi

Erschienen in: Medical Oncology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Cancer testis antigens (CTAs) have normal expression restricted in the testis and also inappropriate expression in various tumor types. Special and favorable characteristics of these genes, as being immunogenic and therefore having the potential to be used as tumor vaccine, have made them as one of the star attractions of the cancer research. Acute myeloid leukemia (AML) is a highly heterogeneous hematological disorder with various reported changes in gene expression. To find new CTA genes in AML, we analyzed the expression pattern of four testis-specific genes AURKC, OIP5, PIWIL2 and TAF7L using real-time quantitative PCR in 51 AMLs and 6 myelodysplastic syndrome cases in comparison with 33 healthy controls. The expression of the studied genes, noticeably OIP5 and TAF7L, differed between studied groups in a gender-dependent manner. Upregulation of OIP5 was observed only in ~41 % of the female AML patients as compared to the healthy females. The remaining ~59 % of the male AML patients, when compared to the healthy males, displayed downregulation of TAF7L. This finding may affect many aspects of AML such as diagnosis, prognosis assessment and treatment choice.
Literatur
1.
Zurück zum Zitat Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukemia genome. Nature. 2008;456(7218):66–72.PubMedCrossRef Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukemia genome. Nature. 2008;456(7218):66–72.PubMedCrossRef
2.
Zurück zum Zitat Lowenberg B. Acute myeloid leukemia: the challenge of capturing disease variety. Hematol Am Soc Hematol Educ Program. 2008;19074046:1–11.CrossRef Lowenberg B. Acute myeloid leukemia: the challenge of capturing disease variety. Hematol Am Soc Hematol Educ Program. 2008;19074046:1–11.CrossRef
3.
Zurück zum Zitat Dohner H. Implication of the molecular characterization of acute myeloid leukemia. Hematol Am Soc Hematol Educ Program. 2007;18024659:412–9.CrossRef Dohner H. Implication of the molecular characterization of acute myeloid leukemia. Hematol Am Soc Hematol Educ Program. 2007;18024659:412–9.CrossRef
4.
Zurück zum Zitat Bacher U, Kohlman A, Haferlach C. Gene expression analysis in acute myeloid leukemia. Mag Eur Medical Oncol. 2008;1:235–41.CrossRef Bacher U, Kohlman A, Haferlach C. Gene expression analysis in acute myeloid leukemia. Mag Eur Medical Oncol. 2008;1:235–41.CrossRef
5.
Zurück zum Zitat Mobasheri MB, Modarressi MH, Shabani M, Asgarian H, Sharifian RA, Vossough P, Shokri F. Expression of the testis-specific gene, TSGA10, in Iranian patients with acute lymphoblastic leukemia (ALL). Leuk Res. 2006;30(7):883–9 (Epub 2006 Jan 6). Mobasheri MB, Modarressi MH, Shabani M, Asgarian H, Sharifian RA, Vossough P, Shokri F. Expression of the testis-specific gene, TSGA10, in Iranian patients with acute lymphoblastic leukemia (ALL). Leuk Res. 2006;30(7):883–9 (Epub 2006 Jan 6).
6.
Zurück zum Zitat Ghafouri-Fard S, Modarressi M-H. Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med. 2009;12(19566358):395–404.PubMed Ghafouri-Fard S, Modarressi M-H. Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med. 2009;12(19566358):395–404.PubMed
7.
Zurück zum Zitat Simpson AJG, Caballero OL, Jungbluth A, Chen Y-T, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005;5(16034368):615–25.PubMedCrossRef Simpson AJG, Caballero OL, Jungbluth A, Chen Y-T, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005;5(16034368):615–25.PubMedCrossRef
8.
Zurück zum Zitat Ji H, Ehrlich LIR, et al. A comprehensive methylome map of lineage commitment from hematopoietic progenitors. Nature. 2010;467(7313):338–42.PubMedCrossRef Ji H, Ehrlich LIR, et al. A comprehensive methylome map of lineage commitment from hematopoietic progenitors. Nature. 2010;467(7313):338–42.PubMedCrossRef
9.
Zurück zum Zitat Ghafouri-Fard S, Abbasi A, Moslehi H, Faramarzi N, Taba Taba Vakili S, Mobasheri MB, Modarressi MH. Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features. Br J Dermatol. 2010;162(4):772–9 (Epub 2009 Nov 3). Ghafouri-Fard S, Abbasi A, Moslehi H, Faramarzi N, Taba Taba Vakili S, Mobasheri MB, Modarressi MH. Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features. Br J Dermatol. 2010;162(4):772–9 (Epub 2009 Nov 3).
10.
Zurück zum Zitat Mobasheri MB, Jahanzad I, Mohagheghi MA, Aarabi M, Farzan S, Modarressi MH. Expression of two testis-specific genes, TSGA10 and SYCP3, in different cancers regarding to their pathological features. Cancer Detect Prev. 2007;31(4):296–302.PubMedCrossRef Mobasheri MB, Jahanzad I, Mohagheghi MA, Aarabi M, Farzan S, Modarressi MH. Expression of two testis-specific genes, TSGA10 and SYCP3, in different cancers regarding to their pathological features. Cancer Detect Prev. 2007;31(4):296–302.PubMedCrossRef
11.
Zurück zum Zitat Katayama H, Sen S. Aurora kinase inhibitors as anticancer molecules. Biochim Biophys Acta. 2010;1799(20863917):829–39.PubMed Katayama H, Sen S. Aurora kinase inhibitors as anticancer molecules. Biochim Biophys Acta. 2010;1799(20863917):829–39.PubMed
12.
Zurück zum Zitat Naetar N, Hutter S, Dorner D, Dechat T, Korbei B, Gotzmann J, Beug H, Foisner R. LAP2alpha-binding protein LINT-25 is a novel chromatin-associated protein involved in cell cycle exit. J Cell Sci. 2007;120(Pt 5):737–47. Naetar N, Hutter S, Dorner D, Dechat T, Korbei B, Gotzmann J, Beug H, Foisner R. LAP2alpha-binding protein LINT-25 is a novel chromatin-associated protein involved in cell cycle exit. J Cell Sci. 2007;120(Pt 5):737–47.
13.
Zurück zum Zitat Fujita Y, Hayashi T, Kiyomitsu T, Toyoda Y, Kokubu A, Obuse C, Yanagida M. Priming of centromere for CENP-A recruitment by human hMis18alpha, hMis18beta, and M18BP1. Dev Cell. 2007;12(1):17–30. Fujita Y, Hayashi T, Kiyomitsu T, Toyoda Y, Kokubu A, Obuse C, Yanagida M. Priming of centromere for CENP-A recruitment by human hMis18alpha, hMis18beta, and M18BP1. Dev Cell. 2007;12(1):17–30.
14.
Zurück zum Zitat Chun H-K, Chung K-S, Kim HC, Kang J-E, Kang MA, Kim J-T, Choi EH, Jung K-E, Kim M-H, Song EY, Kim S-Y, Won M, Lee HG. OIP5 is a highly expressed potential therapeutic target for colorectal and gastric cancers. BMB Rep. 2010;43(20510019):349–54.PubMedCrossRef Chun H-K, Chung K-S, Kim HC, Kang J-E, Kang MA, Kim J-T, Choi EH, Jung K-E, Kim M-H, Song EY, Kim S-Y, Won M, Lee HG. OIP5 is a highly expressed potential therapeutic target for colorectal and gastric cancers. BMB Rep. 2010;43(20510019):349–54.PubMedCrossRef
15.
Zurück zum Zitat Nakamura Y, Tanaka F, Nagahara H, Ieta K, Haraguchi N, Mimori K, Sasaki A, Inoue H, Yanaga K, Mori M. Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer. Ann Surg Oncol. 2007;14(17151793):885–92.PubMedCrossRef Nakamura Y, Tanaka F, Nagahara H, Ieta K, Haraguchi N, Mimori K, Sasaki A, Inoue H, Yanaga K, Mori M. Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer. Ann Surg Oncol. 2007;14(17151793):885–92.PubMedCrossRef
16.
Zurück zum Zitat Ye Y, Yin D-T, Chen L, Zhou Q, Shen R, He G, Yan Q, Tong Z, Issekutz AC, Shapiro CL, Barsky SH, Lin H, Li J-J, Gao J-X. Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis. PLoS One. 2010;5(10):e13406. Ye Y, Yin D-T, Chen L, Zhou Q, Shen R, He G, Yan Q, Tong Z, Issekutz AC, Shapiro CL, Barsky SH, Lin H, Li J-J, Gao J-X. Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis. PLoS One. 2010;5(10):e13406.
17.
Zurück zum Zitat Kimmins S, Kotaja N, Davidson I, Sassone-Corsi P. Testis-specific transcription mechanisms promoting male germ-cell differentiation. Reproduction. 2004;128(15232059):5–12.PubMedCrossRef Kimmins S, Kotaja N, Davidson I, Sassone-Corsi P. Testis-specific transcription mechanisms promoting male germ-cell differentiation. Reproduction. 2004;128(15232059):5–12.PubMedCrossRef
18.
Zurück zum Zitat Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine. 17th ed. New York: The McGraw-Hill Companies, Inc.; 2008. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine. 17th ed. New York: The McGraw-Hill Companies, Inc.; 2008.
19.
Zurück zum Zitat Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L, Drake TA, Lusis AJ. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 2006;16:995–1004.PubMedCrossRef Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L, Drake TA, Lusis AJ. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 2006;16:995–1004.PubMedCrossRef
20.
Zurück zum Zitat Zhang W, Huang RS, Duan S, Dolan ME. Gene set enrichment analyses revealed differences in gene expression patterns between males and females. Silico Biol. 2009;9(19795565):55–63. Zhang W, Huang RS, Duan S, Dolan ME. Gene set enrichment analyses revealed differences in gene expression patterns between males and females. Silico Biol. 2009;9(19795565):55–63.
21.
Zurück zum Zitat Kaminsky Z, Wang S-C, Petronis A. Complex disease, gender and epigenetics. Ann Med. 2006;38(17438668):530–44.PubMedCrossRef Kaminsky Z, Wang S-C, Petronis A. Complex disease, gender and epigenetics. Ann Med. 2006;38(17438668):530–44.PubMedCrossRef
22.
Zurück zum Zitat Wyman MJ, Agrawal AF, Rowe L. Condition-dependence of the sexually dimorphic transcriptome in Drosophila melanogaster. Evolution. 2010;64(20059540):1836–48.PubMedCrossRef Wyman MJ, Agrawal AF, Rowe L. Condition-dependence of the sexually dimorphic transcriptome in Drosophila melanogaster. Evolution. 2010;64(20059540):1836–48.PubMedCrossRef
23.
24.
Zurück zum Zitat Ellegren H, Parsch J. The evolution of sex-biased genes and sex-biased gene expression. Nat Rev Genet. 2007;8(17680007):689–98.PubMedCrossRef Ellegren H, Parsch J. The evolution of sex-biased genes and sex-biased gene expression. Nat Rev Genet. 2007;8(17680007):689–98.PubMedCrossRef
25.
Zurück zum Zitat Vesselinovitch SD. The sex-dependent difference in the development of liver tumors in mice administered dimethylnitrosamine. Cancer Res. 1969;29:1024–7.PubMed Vesselinovitch SD. The sex-dependent difference in the development of liver tumors in mice administered dimethylnitrosamine. Cancer Res. 1969;29:1024–7.PubMed
26.
Zurück zum Zitat Connallon T, Clark AG. Sex linkage, sex-specific selection, and the role of recombination in the evolution of sexually dimorphic gene expression. Evolution. 2010;64(20874735):3417–42.PubMedCrossRef Connallon T, Clark AG. Sex linkage, sex-specific selection, and the role of recombination in the evolution of sexually dimorphic gene expression. Evolution. 2010;64(20874735):3417–42.PubMedCrossRef
27.
Zurück zum Zitat Reinius B, Shi C, Hengshuo L, Sandhu KS, Radomska KJ, Rosen GD, Lu L, Kullander K, Williams RW, Jazin E. Female-biased expression of long non-coding RNAs in domains that escape X-inactivation in mouse. BMC Genomics. 2010;11(21047393):614. Reinius B, Shi C, Hengshuo L, Sandhu KS, Radomska KJ, Rosen GD, Lu L, Kullander K, Williams RW, Jazin E. Female-biased expression of long non-coding RNAs in domains that escape X-inactivation in mouse. BMC Genomics. 2010;11(21047393):614.
28.
Zurück zum Zitat Deschler B, Lübbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107(9):2099–107.PubMedCrossRef Deschler B, Lübbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer. 2006;107(9):2099–107.PubMedCrossRef
29.
Zurück zum Zitat Cheng Y, Buffone MG, Kouadio M, Goodheart M, Page DC, Gerton GL, Davidson I, Wang PJ. Abnormal sperm in mice lacking the Taf7l gene. Mol Cell Biol. 2007;27(17242199):2582–9.PubMedCrossRef Cheng Y, Buffone MG, Kouadio M, Goodheart M, Page DC, Gerton GL, Davidson I, Wang PJ. Abnormal sperm in mice lacking the Taf7l gene. Mol Cell Biol. 2007;27(17242199):2582–9.PubMedCrossRef
30.
Zurück zum Zitat Gan B, Sahin E, Jiang S, Sanchez-Aguilera A, Scott KL, Chin L, Williams DA, Kwiatkowski DJ, DePinho RA. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proc Natl Acad Sci USA. 2008;105(19052232):19384–9.PubMedCrossRef Gan B, Sahin E, Jiang S, Sanchez-Aguilera A, Scott KL, Chin L, Williams DA, Kwiatkowski DJ, DePinho RA. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization. Proc Natl Acad Sci USA. 2008;105(19052232):19384–9.PubMedCrossRef
31.
Zurück zum Zitat Slattery SD, Mancini MA, Brinkley BR, Hall RM. Aurora-C kinase supports mitotic progression in the absence of Aurora-B. Cell Cycle (Georgetown, Tex). 2009;8(18):2984–94. Slattery SD, Mancini MA, Brinkley BR, Hall RM. Aurora-C kinase supports mitotic progression in the absence of Aurora-B. Cell Cycle (Georgetown, Tex). 2009;8(18):2984–94.
32.
Zurück zum Zitat Ulisse S, Delcros JG, Baldini E, Toller M, Curcio F, Giacomelli L, Prigent C, Ambesi-Impiombato FS, D’Armiento M, Arlot-Bonnemains Y. Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues. Int J Cancer. 2006;119(2):275–82.PubMedCrossRef Ulisse S, Delcros JG, Baldini E, Toller M, Curcio F, Giacomelli L, Prigent C, Ambesi-Impiombato FS, D’Armiento M, Arlot-Bonnemains Y. Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues. Int J Cancer. 2006;119(2):275–82.PubMedCrossRef
Metadaten
Titel
Expression analysis of four testis-specific genes AURKC, OIP5, PIWIL2 and TAF7L in acute myeloid leukemia: a gender-dependent expression pattern
verfasst von
Fatemeh Yazarloo
Reza Shirkoohi
Maryam Beigom Mobasheri
Amirhossein Emami
Mohammad Hossein Modarressi
Publikationsdatum
01.03.2013
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 1/2013
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-012-0368-8

Weitere Artikel der Ausgabe 1/2013

Medical Oncology 1/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.